Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas
Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas have?
Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas has 76 citations in the OpenAlex counts ScholarIQ stores.
When was Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas published?
Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas has 2019 year in the ScholarIQ index.
What is the open-access status of Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas?
Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas has green oa status in the ScholarIQ index.
What is the DOI of Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas?
The DOI for Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas is on the source record.
What is the PMID of Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas?
The PMID for Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas is on the source record.
What is the OpenAlex record for Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas?
The OpenAlex for Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas is on the source record.